The goal of this cluster Randomised Controlled Trial (cRCT) is to evaluate the impact and effectiveness of demand-side incentives (DSIs) in improving immunisation coverage and reducing the burden of zero-dose children between the age of 12-23months in Nigeria.
The study seeks to answer the following questions
1. What is the impact of demand-side incentives on increasing immunization coverage in the selected subnational regions of Nigeria? 2. What is the effect of demand-side incentives on reducing the zero-dose burden in selected subnational regions in Nigeria? 3. What is the effect of various demand-side incentive schemes on improving the timeliness of vaccination among children aged 0 to 23 months in the selected subnational regions of Nigeria? 4. What is the impact of different demand-side incentive schemes on enhancing the immunization knowledge and perception of caregivers with children aged 0 to 23 months in the selected subnational regions Nigeria by December 2025.
None
None
Parallel
Transportation Voucher, Comunity engagement and microplannnig support
Other interventionTransportation vouchers will be provided to caregivers of eligible children after vaccination at designated routine immunisation health facilities. This is in addition to support for microplaning (technical assistance) for these routine immunisation health facilities and comunity engagement at their catchment areas.
Direct Facility Funding, Community Engagement, and Microplaning Support
Other interventionDirect funding will be provided to designated routine immunisation health facilities monthly, in addition to weekly performance monitoring and quarterly financial capacity building. Also, there will be support for microplaning (technical assistance) for these routine immunisation health facilities and comunity engagement at their catchment areas.
Transportation Voucher, Direct Facility Funding, Community engagement and Microplanning support
Other interventionTransportation vouchers will be provided to caregivers of eligible children after vaccination at designated routine immunisation health facilities. Direct funding will be provided to designated routine immunisation health facilities monthly, in addition to weekly oerformance monitoring and quarterly financial capacity building. Also, there will be support for microplaning (technical assistance) for these routine immunisation health facilities and comunity engagement at their catchment areas.
proportion of identified stakeholders routinely engaged during implementation
Number of identified stakeholders mapped out from inception divided by the Number of identified stakeholders engaged on a routine basis during implementation
Proportion of planned stakeholders engagement meetings conducted
Number of Planned stakeholders engagement meetings planned divided by the Number of planned engagement meetings conducted
Number of households enrolled and receiving DSI's
Number of households successfully enrolled and benefitting from DSI's
Proportions of Health facilities in intervention communities with updated microplans developed with the communities
Number of Health facilities in intervention communities with an updated micro plan co-developed with the participation of the host divided by the Total number of health facilities within the Intervention communities
Cost per individual for enrolment and provision of DSI's
Total amount spent on provision of DSI's per country divided by the Total number of individuals provided with DSI's per country
Cost per percentage point increase in coverage
Total amount spent on enrolment and Provision of DSI's per cluster divided by percentage increase in coverage per cluster
Proportion of household receiving DSI who feel more accepting of vaccines
Number of households receiving DSI who feel more accepting of vaccines divided by Number of households successfully enrolled and receiving DSI's
Proportion of Households in intervention communities who identify non-cash DSI as a source of Vaccine information
Number of households in intervention communities who identify non-cash DSI as a source of vaccine information divided by the Total number of households surveyed in intervention communities
Click on the lead sponsor to view all of their trials.
Corona Management Systems
Lead sponsor
Kwara State Primary Healthcare Development Agency
Collaborator
Oyo State Primary Healthcare Board
Collaborator
